# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T19:34:01.498382
**Route:** Direct Google API + PDF
**Tokens:** 23518 in / 977 out
**Response SHA256:** d4ec2f43a3286735

---

I have reviewed the draft paper "State Insulin Copay Cap Laws and Diabetes Mortality: A Difference-in-Differences Analysis" for fatal errors.

### **FATAL ERROR 1: Internal Consistency**
*   **Location:** Table 5/6 (page 20) vs. Table 8 (page 24)
*   **Error:** The TWFE coefficients for the same specification do not match. Table 6, Column 1 (labeled "TWFE") reports a coefficient of **-0.242** with an SE of **1.963**. However, Table 8, Panel A (labeled "TWFE + COVID death rate") reports a coefficient of **0.274** with an SE of **1.929**, which matches Column 2 of Table 6. More importantly, the text on page 24 refers to "Table 7: Robustness Checks," but the table below it is labeled "Table 8."
*   **Fix:** Ensure all table numbers are sequential and that coefficients reported in the robustness tables exactly match the primary results tables where specifications overlap.

### **FATAL ERROR 2: Internal Consistency / Regression Sanity**
*   **Location:** Table 6, Column 3, Row "Post Copay Cap" (page 20)
*   **Error:** The coefficient for the log specification is reported as **0.050** with an SE of **0.098**. However, the abstract (page 1) and text (page 19) claim a "precisely estimated null effect" and "modest reductions." A coefficient of 0.050 in a log model implies a 5% *increase* in mortality. Furthermore, the 95% CI in Table 8 for "CS-DiD (log mortality)" is listed as **[-0.117, 0.259]**. This interval is heavily skewed toward a large mortality *increase* (up to 25%), which contradicts the paper's narrative of a "precise null" or "modest reductions."
*   **Fix:** Re-run the log specification and check the sign. If the estimate is indeed positive, the text must be updated to reflect that the point estimate suggests an increase, even if statistically insignificant.

### **FATAL ERROR 3: Regression Sanity**
*   **Location:** Table 6, Column 2, Row "COVID Death Rate" (page 20)
*   **Error:** The coefficient is **0.000** and is marked as statistically significant (*** p < 0.01**). 
*   **Fix:** This is a rounding/scaling error. Mortality rates are "per 100,000," while death counts (the control) are likely in raw units. The coefficient is too small for the displayed precision. Rescale the variable (e.g., COVID deaths per 100,000) so a meaningful coefficient can be displayed.

### **FATAL ERROR 4: Completeness**
*   **Location:** Page 12, Table 1
*   **Error:** Table 1 is empty; it contains only a title ("Summary Statistics") followed immediately by Table 2.
*   **Fix:** Populate Table 1 with the intended policy summary statistics or remove the placeholder title and renumber subsequent tables.

### **FATAL ERROR 5: Data-Design Alignment**
*   **Location:** Table 4 (page 13) vs. Figure 1 (page 18)
*   **Error:** Figure 1 plots "GA" (Georgia) and "LA" (Louisiana) under the 2024 treatment cohort. However, Table 4 lists Georgia's treatment year as **2024** and Louisiana's as **2024**, but then lists Indiana as **2025**. The abstract and text (page 7) state that 26 states enacted laws, but only 17 are used for analysis. If the data ends in 2023, anyone with a "Treatment Year" of 2024 has zero post-treatment observations. While the student correctly reclassifies them as "not-yet-treated," Figure 1 visually presents them as part of the staggered rollout in a way that implies they contribute to the estimate.
*   **Fix:** Clarify in Figure 1 or the data section that these states contribute zero post-treatment days to the primary ATT calculation.

**ADVISOR VERDICT: FAIL**